143 related articles for article (PubMed ID: 7548837)
21. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.
Jiang MC; Yang-Yen HF; Lin JK; Yen JJ
Oncogene; 1996 Aug; 13(3):609-16. PubMed ID: 8760302
[TBL] [Abstract][Full Text] [Related]
23. [Better understanding of the biology of cancer cells].
Klein G
Lakartidningen; 2000 Jul; 97(28-29):3260-4. PubMed ID: 10997012
[TBL] [Abstract][Full Text] [Related]
24. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
[TBL] [Abstract][Full Text] [Related]
25. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
[TBL] [Abstract][Full Text] [Related]
26. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
Gottlieb E; Lindner S; Oren M
Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860
[TBL] [Abstract][Full Text] [Related]
27. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
29. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N; Rock S
Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
[TBL] [Abstract][Full Text] [Related]
30. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53.
Komarova EA; Diatchenko L; Rokhlin OW; Hill JE; Wang ZJ; Krivokrysenko VI; Feinstein E; Gudkov AV
Oncogene; 1998 Sep; 17(9):1089-96. PubMed ID: 9764819
[TBL] [Abstract][Full Text] [Related]
31. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
32. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
33. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis.
Kopnin BP
Biochemistry (Mosc); 2000 Jan; 65(1):2-27. PubMed ID: 10702637
[TBL] [Abstract][Full Text] [Related]
34. p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells.
Yang T; Namba H; Hara T; Takmura N; Nagayama Y; Fukata S; Ishikawa N; Kuma K; Ito K; Yamashita S
Oncogene; 1997 Apr; 14(13):1511-9. PubMed ID: 9129141
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical study of radiation-induced apoptosis and oncogenes].
Hasegawa M; Yamakawa M; Mitsuhashi N; Furuta M; Sakurai H; Hayakawa K; Niibe H
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Sep; 55(11):779-80. PubMed ID: 8532513
[TBL] [Abstract][Full Text] [Related]
36. [Interaction of oncogene and anti-oncogene products].
Zang J; Zhou AR
Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):34-7. PubMed ID: 1829543
[No Abstract] [Full Text] [Related]
37. [Oncogenes and tumor-suppressor genes].
Izumiya M; Nakagama H
Nihon Rinsho; 2011 Apr; 69 Suppl 3():72-6. PubMed ID: 22213934
[No Abstract] [Full Text] [Related]
38. Oncogenes and growth factors--an updating.
Ernberg IT
Eur J Surg Suppl; 1991 May; (561):15-20. PubMed ID: 1720043
[No Abstract] [Full Text] [Related]
39. [Protein P53, protector of genome integrity: its role in carcinogenesis].
Bellahcene A; Merville MP; Gielen J; Lambotte R; Simar L; Castronovo V
Rev Med Liege; 1994 May; 49(5):274-84. PubMed ID: 8023054
[No Abstract] [Full Text] [Related]
40. Molecular and cytogenetic alterations in human pancreatic cancer: the role of tumor suppressor genes.
Ruggeri B; Zhang SY; Klein-Szanto AJ
Prog Clin Biol Res; 1992; 376():245-60. PubMed ID: 1528921
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
